Jacobs Levy Equity Management
RXST icon

Jacobs Levy Equity Management’s RxSight RXST Stock Holding History

Jacobs Levy Equity Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.81M Sell
998,569
-67,752
-6% -$409K 0.02% 442
2026
Q1 		$6.57M Buy
1,066,321
+881,200
+476% +$7.32M 0.03% 371
2025
Q4 		$1.93M Buy
+185,121
New +$1.86M 0.01% 584

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jacobs Levy Equity Management's RXST Position: Q2 2026 in Review

Jacobs Levy Equity Management reduced its RxSight (RXST) stake by 6.4% in Q2 2026, selling an estimated $409K and leaving 998,569 shares worth $4.81M. The position accounts for 0.02% of the portfolio, ranked #442.

Jacobs Levy Equity Management first reported a position in RXST in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.57M in Q1 2026. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Jacobs Levy Equity Management held 998,569 shares of RxSight worth $4.81M as of Q2 2026.
  • Jacobs Levy Equity Management sold 67,752 RxSight shares in Q2 2026, an estimated $409K.
  • RxSight made up 0.02% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #442 holding.
  • Jacobs Levy Equity Management first reported a position in RxSight in Q4 2025 and has held it in 3 quarters since.
  • Jacobs Levy Equity Management's RxSight position peaked at $6.57M in Q1 2026.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.